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a b s t r a c t 
The human LINE-1 / L1 ORF2 protein is a multifunctional enzyme which plays a vital role in the life
cycle of the human L1 retrotransposon. The protein consists of an endonuclease domain, followed by a
central reverse transcriptase domain and a carboxy-terminal C-domain with unknown function. Here,
we explore the nucleic acid binding properties of the 180-amino acid carboxy-terminal segment (CTS)
of the human L1 ORF2p in vitro . In a series of experiments involving gel shift assay, we demonstrate
that the CTS of L1 ORF2p binds RNA in non-sequence-speciﬁc manner. Finally, we report that mutations
destroying the putative Zn-knuckle structure of the protein do not signiﬁcantly affect the level of RNA
binding and discuss the possible functional role of the CTS in L1 retrotransposition. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical
Societies. Open access under CC BY-NC-ND license. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1. Introduction 
Long Interspersed Nuclear Element-1 (LINE-1) or L1 elements are
active members of an autonomous family of non-LTR retrotrans-
posons and comprise up to 17% of the human genome. The major-
ity are inactive due to mutations, truncations and recombination, but
about one hundred copies are retrotransposition-competent [ 1 ]. 
Full-length human L1 elements are about 6 kb long and contain
two non-overlapping open reading frames (ORFs) encoding essential
proteins for its re-integration into the genome. The ORF1 encodes
a 40 kDa RNA-binding protein, which associates with L1 RNA [ 2 ]
and functions as a chaperone [ 3 , 4 ]. The product of ORF2 is a 149
kDa multifunctional polymerase with endonuclease [ 5 , 6 ], RNA- and
DNA-dependent DNA polymerase activities [ 7 , 8 ]. L1 ORF2p reverse
transcriptase (RT) is a highly processive polymerase unlike retroviral
RTs [ 9 ]. It seems that both proteins interact with their own L1 RNA in
a cis preference manner [ 10 ] forming ribonucleic acid particles (RNP)
that are probable intermediates of retrotransposition [ 11 –13 ]. It has
been proposed that the L1 ORF2 protein uses nicked DNA as a primer
to initiate cDNA synthesis on the RNA template in a target-primed
reverse transcription (TPRT) reaction [ 14 ] originally demonstrated for
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The L1 ORF2 polypeptide forms an AP-like endonuclease (EN) do-
main at the N-terminus, then an RT domain followed by the cysteine-
rich carboxy-terminal part, the C-domain [ 16 ], which contains a pu-
tative CCHC zinc knuckle structure. The EN, RT and C-domain are
essential for successful L1 retrotransposition [ 17 ]. Thus, mutation of
the C-domain zinc ﬁnger severely affects the retrotransposition fre-
quency of L1 elements in the cell culture-based retrotransposition
assay [ 17 –19 ], reduction in the content of ORF2p in RNP and dra-
matic decrease in RT activity in L1 RNP as well as disperse nuclear
localization of L1 RNP [ 13 ]. However the function of the C-domain,
particularly the putative CCHC zinc knuckle structure remains un-
clear. Unlike retroviral RTs, where one third of their polypeptide chain
at the C-terminus is reserved with an RNaseH domain [ 20 ], the long
C-terminal portion of human L1 ORF2p bears neither sequence sim-
ilarities [ 21 , 22 ] nor activities [ 9 ] corresponding to RNase H. Thus, an
elucidation of C-domain function in L1 retrotransposition is of great
interest. 
We have previously demonstrated that human L1 RT (L1 ORF2p)
is a highly processive polymerase, able to incorporate hundreds of
nucleotides per template binding event [ 9 ]. At that time, we hypoth-
esized that L1 ORF2p C-domain, enriched with basic amino acid (aa)
residues, was able to provide a more stable interaction of the L1 RT
with L1 mRNA during DNA synthesis, and contributed to high proces-
sivity of L1 RT in vitro . 
In the research presented here, we have examined the nucleic acid
binding activity of a distal 180 aa C-terminal portion of L1 ORF2 pro-
tein, namely the carboxy-terminal segment (CTS). L1 ORF2p CTS was
expressed individually in bacteria followed by its puriﬁcation andan Biochemical Societies. Open access under CC BY-NC-ND license.
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ixamination of nucleic acid binding properties in a series of experi- 
ents involving gel shift assay with wild type CTS and its mutant form 
arrying aa substitutions disrupting CCHC zinc knuckle structure. We 
ave demonstrated that L1 ORF2p CTS has a high non-speciﬁc afﬁnity 
o RNA in the nanomolar range. 
This data allowed us to suggest that the carboxy-terminal seg- 
ent provides high processivity for L1 ORF2p reverse transcriptase 
n comparison with that of retroviral RTs. Furthermore, non-speciﬁc 
NA-binding activity of L1 ORF2p CTS may contribute to both cis - 
reference of L1 ORF2 protein to its own RNA, and a move of non 
utonomous mobile elements. 
. Materials and methods 
pSM42, containing the ORF2 of the active human L1 element LRE1, 
as a gift from Prof. H. Kazazian. The numbering of the L1.2 sequence 
s that of Genbank: M80343 . 
A polypeptide sequence of the ORF2 protein from 1096 to 1275 aa 
as cloned as a fusion with thioredoxin (TRX). For this purpose, a 
.54 kb fragment of ORF2 corresponding to the 180 aa sequence was 
mpliﬁed with PCR using primers listed in Supplementary data SD1 ; 
nd ligated into pET32b (Novagen) within EcoRI and XhoI sites. The 
esulting plasmid pET-TRX-CTS coded for a fusion of TRX and a C- 
erminal 21.3 kDa polypeptide of L1 ORF2p, referred as rCTS. 
Additional materials and methods including protein expression 
nd puriﬁcation, protein analysis, RNA and DNA template synthesis, 
lectrophoretic mobility shift assay and statistics are detailed in SD1 . 
. Results 
.1. Puriﬁcation of recombinant carboxy-terminal segment of L1 ORF2p 
Human L1 ORF2p is 149 kDa multifunctional enzyme comprising 
f distinguished domains: EN and RT, both of which may contribute 
o nucleic acid binding activity ( Fig. 1 A). Therefore, we decided that 
ndividual domain characterization would be the preferred option. In 
his manner EN has been successfully expressed, puriﬁed and char- 
cterized [ 5 ]. The exact boundaries of the RT domain and C-domain 
re not yet deﬁned, but the localization of the putative Zinc knuckle 
tructure is predicted. Therefore, the cystein-rich carboxy-terminal 
olypeptide sequence of L1 ORF2 was analyzed for prediction of RNA 
inding residues / motifs using the packages BindN [ 23 ] and RNABindR 
 24 ]. Results of this prediction demonstrated a cluster distribution of 
NA binding residues in the C-domain of the protein ( Fig. 1 B). Taking 
nto consideration both the aa distribution and the C-domain size, 
ne would suggest a subdomain organization of the C-domain. 
The distal C-terminal polypeptide sequence of the ORF2 protein 
1096–1275 aa) containing both the putative Zn-knuckle structure 
nd multiple predicted RNA binding residues was selected and re- 
erred to as CTS (carboxy-terminal segment) ( Fig. 1 C). L1 ORF2p CTS 
as inserted into pET32b plasmid DNA resulting in a fusion protein 
f ≈40 kDa. This recombinant protein, referred to as rCTS, is fusion 
rotein of CTS with TRX and ﬂanked with 6 His tag. 
rCTS was expressed in soluble form and puriﬁed using metal afﬁn- 
ty chromatography to near homogeneity ( Fig. 1 C) as detailed in 
upplementary material (SD1) . The integrity and the concentration 
f all recombinant proteins were veriﬁed by Silver staining gel and 
ierce BSA protein assay, respectively. 
.2. The CTS of L1 ORF2p is an RNA binding domain 
Wild type rCTS was used for studying CTS–nucleic acid (NA) inter- 
ctions. This C-terminal region of L1 ORF2p has a potential Zn-knuckle 
tructure as well as being rich in basic aa residues; about 14% of the 
otal aa are either lysines or arginines, and the overall pI value of CTS 
s 9.1. To examine the hypothesis that CTS is a nucleic acid binding do- 
main within L1 ORF2p, we performed an electrophoretic mobility 
shift assay (EMSA) using various templates, dsDNA and ssRNA. The 
complex rCTS:NA was observed only in the presence of RNA as tem- 
plate in physiological concentrations of monovalent cation and pH 
( Fig. 2 A) demonstrating that CTS has RNA binding activity. 
3.3. The CTS of L1 ORF2p has a high non-sequence speciﬁc afﬁnity to 
RNA 
The binding afﬁnity of CTS to ssRNA was analyzed by EMSA. In 
this experiment, a known amount of rCTS was titrated into a con- 
stant amount of tested RNA. To exclude a contribution of TRX or 6 
Histag into RNA binding, we performed a control EMSA reaction in 
the presence of the puriﬁed TRX-6Histag-Stag-6Histag at the same 
conditions ( Fig. 2 B). In order to assess the percentage of RNA bind- 
ing, band intensities were measured by densitometric scanning of 
unbound and bound RNA. The Kd value for binding of rCTS to RNA 
is apparently in the nanomolar range as could be visualized from 
the binding pattern on Fig. 2 B. Based on the amount of free RNA in 
each lane, the dissociation constant value for rCTS bound to RNA ap- 
pears in the range of 50–100 nM. We also examined RNA binding by 
rCTS applying the Hill binding model. The Hill coefﬁcient was cal- 
culated by ﬁtting a non-linear least squares regression model to the 
experimental data points using the GraphPad Prism 4 software ( Fig. 
2 C). The best ﬁt value for the Hill coefﬁcient was 1.5, suggesting that 
more than one rCTS molecule bound to RNA under the experimental 
conditions. The apparent dissociation constant was calculated to be 
Kd = 63 nM. A discrete oligomerization of rCTS was observed when 
amounts of RNA and rCTS were increased in the reaction ( SD1 ). The 
size of RNA tested, the presence of more than one binding site on 
RNA molecule and protein–protein interactions could contribute to 
multiply non-speciﬁc binding. 
To study the RNA-binding speciﬁcity of rCTS, we replaced the 
3 ′ UTR L1 RNA in the binding assay with different RNA fragments 
in the size range of 100–500 nt, which were derived from the dif- 
ferent locations within the L1 3 ′ UTR and the pET32b plasmid DNA. 
We found that each of these RNA fragments had a CTS binding proﬁle 
similar to that of the full length 3 ′ UTR of L1 RNA (data not shown). 
These results demonstrated that CTS has a high afﬁnity to RNA and 
possesses a broad RNA-binding speciﬁcity. The minimal size of RNA 
bound to rCTS was 100 nt under given experimental conditions. 
Thus, the C-terminal sequence (1096–1275 aa) of L1 ORF2p binds 
to RNA with high afﬁnity but without apparent sequence speciﬁcity 
in vitro . 
3.4. The Zn-knuckle structure does not affect the RNA binding afﬁnity 
level of the CTS of L1 ORF2p 
To evaluate the contribution of the Zn-knuckle structure to the 
RNA binding afﬁnity of CTS, four Cys in its aa sequence were replaced 
by Ser ( Fig. 1 C) using the GeneTailor mutagenesis system. This mutant 
form of CTS was expressed and puriﬁed as described above ( Fig. 1 C, 
SD1 ). We hypothesized that if Zn-knuckle structure affects RNA bind- 
ing, then no binding by rCTS-mut will be detected at the observed Kd 
for rCTS. The RNA binding of rCTS-mut was tested in EMSA under the 
same conditions as wild type rCTS and both puriﬁed rCTS-mut and 
rCTS at ∼70 nM were incubated with same amount of 380 nt RNA ( Fig. 
2 D). No signiﬁcant loss in RNA binding activity was observed. These 
results demonstrated that the Zn-knuckle structure does not affect 
the RNA binding afﬁnity level by CTS of L1 ORF2p. Unfortunately, we 
were not able to register any speciﬁc interactions of L1 ORF2p with 
L1 RNA, probably due to low sensitivity of the technique. 
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Fig. 1. (A) Schematic representation of the full length polypeptide encoded by human L1 ORF2 (aa numbering according to GenBank sequence M80343 ). The endonuclease domain, 
(EN), reverse transcriptase, (RT), and the 180 aa carboxy-terminal segment (CTS) are shown. The putative Zn-knuckle structure is marked by a red pin within the CTS. (B)The 
results of the BindN [ 23 ] and RNABindR [ 24 ] prediction software for the 180 aa CTS polypeptide. The black and blue asterisks indicate predicted RNA-binding amino acid residues 
identiﬁed with the BindN and RNABindR, respectively. The putative Zn-knuckle sequence is in red. (C) Schematic diagrams of expression plasmids (left). SDS–PAGE of the puriﬁed 
recombinant fusion proteins containing CTS (rCTS, 40 kDa) visualized by silver staining (right). The Zn-knuckle sequence and aa substitutions are presented. The position of 6His 
tags is indicated. Theoredoxin, TRX, lysate, L, wild type of rCTS, WT, Zn ﬁnger mutant form of rCTS, Mut. 
Fig. 2. (A) Determination of rCTS binding speciﬁcity in physiological conditions using EMSA with various templates, dsDNA and ssRNA. The complex(es) rCTS:NA was observed 
only in the presence of RNA as template. (The molar ratio of protein:NA in reaction mix was similar.) (B) Determination of the binding afﬁnity of rCTS to ssRNA. The concentration 
of rCTS was in the range 0–150 nM, whilst the amount of 380 nt RNA was constant at 30nM. The complexes RNA:protein and free probes are marked. An excess of puriﬁed TRX was 
used in a control EMSA reaction to eliminate any contribution of TRX into NA binding. pET32b (Novagen) was used to express TRX which consists of TRX-6Histag-Stag-6Histag. 
RNA markers, M. (C) Examination of the RNA binding by rCTS using the Hill model. The data are plotted as the fraction of bound RNA versus molar concentration of rCTS. The Hill 
coefﬁcient and Kd were calculated by ﬁtting a non-linear least squares regression model to the experimental data points using the GraphPad Prism 4 software. The Hill coefﬁcient 
was 1.5, the apparent Kd was 63 nM. (D) Evaluation of contribution of Zn-knuckle structure on the RNA binding properties of CTS. EMSA was performed with wt and mutant form 
of rCTS ( ∼70 nM) in the presence of the same amount of 380 nt RNA. 
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a. Discussion 
In the present work, we have further elucidated the properties of 
he carboxy-terminal segment of the L1 ORF2 protein. In a series of 
xperiments involving gel shift assay with a recombinant CTS and dif- 
erent nucleic acid templates, we demonstrated that the C-terminal 
80 residues of L1 ORF2p are sufﬁcient for a strong interaction with 
NA in vitro, in an apparently non-speciﬁc manner. This RNA binding 
as cooperative and saturable, with an apparent dissociation con- 
tant of the low nanomolar range ( Fig. 2 B and C). Several factors 
ould contribute to this observation: the size of the RNA molecule, a 
on-speciﬁc RNA binding activity of rCTS and / or protein–protein in- 
eractions. Importantly, comparable high afﬁnity has been observed 
or mouse L1 ORF1 protein, which binds RNA with nanomolar afﬁnity 
nd little regard for nucleotide sequence in physiological concentra- 
ions of monovalent cation [ 4 ]. 
The high afﬁnity of L1 ORF2p CTS to RNA suggests that it may 
lay an important role in cDNA synthesis, nucleic acid interactions 
nd in the formation of L1 RNP. We have previously demonstrated 
hat L1 ORF2p reverse transcriptase alone is able to polymerize hun- 
reds of nucleotides per template binding event and hypothesized 
hat the unique positively charged C-domain of L1 ORF2 protein may 
e responsible for this phenomenon [ 9 ]. Such an intrinsic domain can 
rovide a tight, but ﬂexible binding with template, promoting long 
hain DNA synthesis without accessory proteins [ 25 ]. RNA-binding 
roperties of CTS make it an attractive candidate for the role of an in- 
ramolecular processivity factor of L1 RT. Moreover, the RNA binding 
ctivity of L1 ORF2p CTS may also protect L1 RNA, stabilize L1 RNA- 
arget primer complex and facilitate the ﬁrst steps in TPRT during 
ntegration of L1 element into host genome. 
At the same time our data suggest that the RNA-binding C- 
erminus of L1 ORF2p is liable for the cis -preference of the protein 
o its own RNA [ 10 , 26 ], as well as formation of an L1 ribonucleo- 
rotein particle [ 11 , 13 ]. Apparently, the newly translated L1 ORF2 
rotein immediately binds to a native template with its high afﬁn- 
ty C-terminal tail. One could not exclude that, not only non-speciﬁc 
inding occurs but also speciﬁc interactions of L1 ORF2p with cis -sites 
f L1 template. However, in our experiments with the L1 3 ′ UTR RNA 
ragment, such binding either masked by non-speciﬁc interaction or 
is -sites are not presented. It is also possible that CTS within the full 
ength ORF2p can bind L1 RNA in a sequence-speciﬁc manner. 
Finally, non-speciﬁc RNA-binding activity of L1 ORF2p CTS is most 
ikely involved in a move of non-autonomous mobile elements, such 
s Alu and SVAs. These elements lack RT-encoded sequences and uti- 
ize RT activities provided by autonomous retrotransposons for their 
ransposition. It is believed that Alu and SVA elements are mobi- 
ized by the L1 retrotransposition machinery via the TPRT mechanism 
 27 , 28 ]. The RNA-binding CTS of L1 ORF2p may directly participate 
n this process, capturing distant transcripts of non-autonomous ele- 
ents for subsequent reverse transcription and insertion in the host 
enome. 
We found no evidence for contribution of the Zn-knuckle struc- 
ure in RNA recognition and binding. This is possible explained by the 
on-speciﬁc nature of electrostatic interactions between the basic 
esidues of CTS involved and the RNA phosphate groups. Therefore, 
utations in the CTS destroying the Zn-knuckle structure, did not 
igniﬁcantly affect the afﬁnity level to RNA because non-speciﬁc in- 
eractions occurred even in the absence of the Zn-knuckle structure. 
Taking into consideration our data and the results of the cell 
ulture-based retrotransposition assay where mutation of the zinc 
nuckle structure resulted in considerably decrease of L1 retrotrans- 
osition rates [ 17 –19 ], diffuse nuclear localization of L1 RNP, reduced 
ontent of ORF2p in RNP and consequently a decrease in RT activity in 
1 RNP [ 13 ], we would speculate that this structure may be primarily 
esponsible for the speciﬁc protein–protein and cis -sites interactions s well as L1 RNP formation. In conclusion, our report demonstrates for the ﬁrst time RNA bind- 
ing features of the CTS domain of the human L1 ORF2 protein. We hy- 
pothesise that the observed non-speciﬁc binding to RNA by the CTS 
domain is due to electrostatic interactions between the positively 
charged amino acid residues within this domain and the phosphate 
groups of the RNA. Without knowing the exact structure of the CTS, 
it is difﬁcult to explain its interaction with RNA in a non-sequence 
speciﬁc manner and lack of binding with dsDNA. Thus, it would be 
very interesting to clarify the architecture of CTS, and the nature of 
its interaction with nucleic acids. 
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